Quality of antiepileptic drugs in Vietnam

被引:11
作者
Mac, Tu Wong [1 ]
Gaulier, Jean-Michel [2 ]
Van Tuan Le [3 ]
Anh Nhi Vu [3 ]
Preux, Pierre-Marie [1 ]
Ratsimbazafy, Voa [1 ]
机构
[1] Inst Neuroepidemiol & Trop Neurol EA3174, Fac Med & Pharm, F-87025 Limoges, France
[2] Univ Hosp, Dept Pharmacol & Toxicol EA3838, Limoges, France
[3] Fac Med & Pharm, Dept Neurol, Ho Chi Minh Ville, Vietnam
关键词
epilepsy; quality; anti-epileptic drugs; Vietnam; carbamazepin; phenytoin;
D O I
10.1016/j.eplepsyres.2008.03.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this research was to evaluate the quality of anti-epileptic drugs (AEDs) in a central city of South Vietnam. A cross-sectional study was conducted in all the outlets for AEDs. Out of 33 pharmacies 54% had AEDs. Where the drugs were available, 89% of the pharmacies, 10 units were purchased, choosing the cheapest ones. The information on the packaging, the galenic form and the aspect of the drug were studied. Each sample's tablet was weighted and was considered satisfactory if it was within +/-10% of the average. A HPLC method was used for dosing the active ingredient (AI), which was considered satisfactory within +/-10% of the theoretical value. Eight samples were based on carbamazepin and eight on phenytoin. None of the 16 samples collected were past their expiring date. Tablets were homogeneous in shape, dimension and color. The uniformity of weight was satisfactory but the AI results were alarming for Carbamazepin and more often for Phenytoin. Only 35% of the tablets were correctly dosed. Because of differences of sensitivities of AEDs to storage conditions, environmental factors (heat, tight and humidity) could be responsible for this result. Best results were achieved in structures where storage seemed to be better. The influence of storage conditions must be further studied to confirm this conclusion. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 50 条
  • [41] Antiepileptic drugs and liver disease
    Ahmed, SN
    Siddiqi, ZA
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2006, 15 (03): : 156 - 164
  • [42] Epilepsy, antiepileptic drugs and dementia
    Beghi, Ettore
    Beghi, Massimiliano
    CURRENT OPINION IN NEUROLOGY, 2020, 33 (02) : 191 - 197
  • [43] Antiepileptic drugs and hormones in children
    Cansu, Ali
    EPILEPSY RESEARCH, 2010, 89 (01) : 89 - 95
  • [44] Epilepsy, Pregnancy, and Antiepileptic Drugs
    Tekin, Betul
    EPILEPSI, 2018, 24 : 41 - 43
  • [45] Fractures, epilepsy, and antiepileptic drugs
    Mattson, RH
    Gidal, BE
    EPILEPSY & BEHAVIOR, 2004, 5 : S36 - S40
  • [46] Antiepileptic Drugs and Liver Disease
    Vidaurre, Jorge
    Gedela, Satyanarayana
    Yarosz, Shannon
    PEDIATRIC NEUROLOGY, 2017, 77 : 23 - 36
  • [47] Cognitive effects of antiepileptic drugs
    Carrizosa Moog, Jaime
    IATREIA, 2009, 22 (04) : 350 - 358
  • [48] Antiepileptic drugs and the immune system
    Beghi, Ettore
    Shorvon, Simon
    EPILEPSIA, 2011, 52 : 40 - 44
  • [49] Teratogenic effects of antiepileptic drugs
    Tomson, Torbjorn
    Battino, Dina
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2008, 17 (02): : 166 - 171
  • [50] Antiepileptic drugs and pregnancy outcomes
    Wlodarczyk, Bogdan J.
    Palacios, Ana M.
    George, Timothy M.
    Finnell, Richard H.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2012, 158A (08) : 2071 - 2090